Elliott D A, Nelson R W, Feldman E C, Neal L A
Veterinary Medical Teaching Hospital, University of California, Davis, USA.
J Vet Intern Med. 1997 May-Jun;11(3):161-5. doi: 10.1111/j.1939-1676.1997.tb00084.x.
Blood glycosylated hemoglobin (GHb) concentration was quantified in 84 healthy cats, 9 cats with stress-induced hyperglycemia, 37 cats with newly diagnosed diabetes mellitus, and 122 diabetic cats treated with insulin or glipizide. Diabetic control was classified as good or poor in insulin-treated or glipizide-treated cats based on review of history, physical examination findings, changes in body weight, and measurement of blood glucose concentrations. Blood GHb concentration was determined using an affinity chromatography assay. Mean blood GHb concentration was similar for healthy normoglycemic cats and cats with transient, stress-induced hyperglycemia, but was significantly (P < .001) higher in untreated diabetic cats when compared with healthy normoglycemic cats. Mean blood GHb concentration was significantly (P < .001) higher in 84 cats with poorly controlled diabetes mellitus when compared with 38 cats in which the disease was well controlled. Mean blood GHb concentration decreased significantly (P < .01) in 6 cats with untreated diabetes mellitus after insulin and dietary treatment. A similar significant (P < .01) decrease in mean blood GHb concentration occurred in 7 cats with poorly controlled diabetes mellitus after diabetic control was improved by an increase in insulin dosage from 1.1 +/- 0.9 to 1.4 +/- 0.6 U/kg/ 24 h and by feeding a diet containing increased fiber content and in 6 cats with transient diabetes mellitus 8.2 +/- 0.6 weeks after discontinuing insulin treatment. There was a significant (P < .01) stress-induced increase in mean fasting blood glucose concentration and mean blood glucose concentration for 12 hours after administration of insulin or glipizide but no change in mean blood GHb concentration in 5 docile diabetic cats 12.2 +/- 0.4 weeks after the cats became fractious as a result of frequent hospitalizations and blood samplings. Results of this study suggest that evaluation of blood GHb concentration may be a clinically useful tool for monitoring glycemic control of diabetes in cats.
对84只健康猫、9只应激性高血糖猫、37只新诊断的糖尿病猫以及122只接受胰岛素或格列吡嗪治疗的糖尿病猫的血液糖化血红蛋白(GHb)浓度进行了定量分析。根据病史、体格检查结果、体重变化和血糖浓度测量,将接受胰岛素或格列吡嗪治疗的猫的糖尿病控制情况分为良好或不佳。采用亲和色谱法测定血液GHb浓度。健康血糖正常的猫和短暂应激性高血糖猫的平均血液GHb浓度相似,但与健康血糖正常的猫相比,未经治疗的糖尿病猫的平均血液GHb浓度显著更高(P <.001)。与38只疾病得到良好控制的猫相比,84只糖尿病控制不佳的猫的平均血液GHb浓度显著更高(P <.001)。6只未经治疗的糖尿病猫在接受胰岛素和饮食治疗后,平均血液GHb浓度显著降低(P <.01)。7只糖尿病控制不佳的猫在胰岛素剂量从1.1±0.9增加到1.4±0.6 U/kg/24小时,并喂食纤维含量增加的饮食后,糖尿病控制得到改善,平均血液GHb浓度也出现了类似的显著降低(P <.01);6只短暂性糖尿病猫在停止胰岛素治疗8.2±0.6周后,平均血液GHb浓度也显著降低。在5只温顺的糖尿病猫因频繁住院和采血变得烦躁不安12.2±0.4周后,给予胰岛素或格列吡嗪后,平均空腹血糖浓度和给药后12小时的平均血糖浓度出现了显著的应激性升高,但平均血液GHb浓度没有变化。本研究结果表明,评估血液GHb浓度可能是监测猫糖尿病血糖控制的一种临床有用工具。